Search

Your search keyword '"Monnereau, Alain"' showing total 480 results

Search Constraints

Start Over You searched for: Author "Monnereau, Alain" Remove constraint Author: "Monnereau, Alain"
480 results on '"Monnereau, Alain"'

Search Results

2. Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort

3. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study

4. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

5. Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort

6. Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

7. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

8. Genetic overlap between autoimmune diseases and non‐Hodgkin lymphoma subtypes

9. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study

10. Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis

11. Reporting tumor genomic test results to SEER registries via linkages.

12. Access to optimal treatment of acute myeloid leukaemia patients is affected by sociodemographic factors: a French population based-study.

13. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

15. Occupational exposure to pesticides and multiple myeloma in the AGRICAN cohort

18. Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

19. Validation of an algorithm for identifying incident cancer cases based on long‐term illness and diagnosis related group program data from the French National Health Insurance Information System (SNDS)

20. Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort

21. Pooled study of occupational exposure to aromatic hydrocarbon solvents and risk of multiple myeloma

22. A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort

23. A genome-wide association study of marginal zone lymphoma shows association to the HLA region.

24. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

25. Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region

26. Épidémiologie descriptive des cancers en France métropolitaine : incidence, survie et prévalence

27. Treatment challenges in and outside a network setting: Head and neck cancers

28. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference

29. Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting

30. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours

31. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting

32. Epidemiology of rare cancers and inequalities in oncologic outcomes

33. Treatment challenges in and outside a network setting: Soft tissue sarcomas

34. Validation of an algorithm for identifying incident cancer cases based on long‐term illness and diagnosis related group program data from the French National Health Insurance Information System (SNDS).

35. PB1855: USE OF MACHINE LEARNING MODEL TO IDENTIFY PATIENTS RECEIVING OPTIMAL TREATMENT AND THE ASSOCIATED NON-BIOLOGICAL FACTORS: A POPULATION-BASED STUDY

38. Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

40. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

44. Data from HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes

45. Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population‐based study in France

48. Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

49. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study

50. Herbicide use in farming and other jobs in relation to non-Hodgkin’s lymphoma (NHL) risk

Catalog

Books, media, physical & digital resources